566PA first-in-human phase I study of GC1118, a novel...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

566PA first-in-human phase I study of GC1118, a novel monoclonal antibody inhibiting epidermal growth factor receptor (EGFR), in patients with colorectal cancer and gastric/GEJ cancer

Oh, D-Y, Lee, K-W, Han, S-W, Kim, J W, Shin, J-W, Jo, S-J, Kim, N H, Woo, A, Won, J, Hahn, S, Lee, H, Kim, W H, Bang, Y-J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy281.112
Date:
October, 2018
File:
PDF, 79 KB
english, 2018
Conversion to is in progress
Conversion to is failed